Where does the money go?
All funds collected via Vaccine Forward are sent directly to the COVAX AMC, which is under the auspices of the Global Alliance for Vaccine and Immunization (GAVI). GAVI has years of experience with various innovative financing programs for immunization projects, one of which is its Accelerated Market Commitment (AMC) concept. COVAX AMC is the financing initiative that GAVI and its partners have launched specifically to help fight Covid-19. Low- and middle-income countries can apply for COVAX AMC funding to provide vaccinations that they would otherwise not be able to afford.
GAVI is an international organization that unites players in the public and private sectors with a shared goal of creating equal access to new and underused vaccines for children living in the world’s poorest countries. GAVI has been working with vaccines and immunization for more than 20 years and has helped vaccinate more than 822 million children in the world’s poorest countries. Based on this experience, GAVI has taken a leading role both in the task to jointly coordinate the development and procurement of vaccines (via COVAX Facility), and also to help the world’s 92 lower-middle and low-income economies fund vaccinations (via COVAX AMC).
Aiming to protect the world from Covid-19 by 2021, Vaccine Forward, together with donor countries and foundations, is striving to help raise the USD 2 billion that is required
More on COVAX AMC, GAVI and WHO
Ending the Covid-19 pandemic: Who is doing what?
To help you find your way through the alphabet soup of acronyms associated with international organizations and collaborations, we’ve created a crash course to get you up to speed with the biggest players.
Let’s begin with perhaps the most familiar of these groups, the World Health Organization (WHO). WHO is well-known as a provider of Covid-19 recommendations, but it also leads a Covid-19 response project called the Access to Covid-19 Tools (ACT) Accelerator. WHO cooperates with the United Nations International Children’s Emergency Fund (UNICEF), the World Bank, the Coalition for Epidemic Preparedness Innovations (CEPI), the Foundation for Innovative New Diagnostics (FIND), the Bill and Melinda Gates Foundation (BMGF), the Global Alliance for Vaccine and Immunization (GAVI) and many more.
The World Health Organization, like any good project leader, has divided the various tasks into different subgroups. Some work to ensure testing is working; some to facilitate the development of treatments; and yet others work to ensure that vaccines will be equally accessible to protect people around the globe. This last project group is known as COVAX and is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI) and the Global Alliance for Vaccine and Immunization (GAVI).
To accomplish this, there are two main platforms. First, there is the COVAX Facility whose task is to ensure a plurality of different vaccine candidates. They are also working to design a fast, effective and orderly process for distributing the doses of the vaccines. Guided by an allocation framework being developed by the WHO, the COVAX Facility will then equitably distribute these doses to help protect the most at-risk groups in all participating countries.
In parallel, COVAX AMC is working to secure funding so that countries without the resources to pay for vaccines will still be able to provide them to those in need.
GAVI is working with UNICEF and the WHO to ensure infrastructure and technical support will be in place to safely deliver Covid-19 vaccines to all those in need.